Please use this identifier to cite or link to this item:
Title: Anti-myelin T cells in multiple sclerosis: pathogenic role and therapeutic strategies
Authors: VAN DER AA, Annegret 
Advisors: STINISSEN, Piet
Issue Date: 2002
Publisher: UHasselt Diepenbeek
Abstract: Multiple sclerosis is generally considered to be a T cell-mediated autoimmune disease, targeting components of the myelin sheaths in the central nervous system. Although there is evidence indicating that autoreactive T cells are the key players in the initiation of chronic inflammation, the exact mechanisms of the onset of disease are not completely understood. This study is aimed to further characterize the potentially pathogenic role of myelin reactive T cells in the disease process. We focused on T cell responses towards a minor component of the myelin that recently has been suggested to play a primary role in MS. Furthermore, a new protocol for T cell vaccination, in which these autoreactive T cells, isolated from CSF, are used as therapeutic targets, was optimized. To obtain information about feasibility, safety and immunological effects of the protocol, T cells from the CSF are used as vaccine cells in a pilot clinical trial involving 5 MS patients.
Document URI:
Category: T1
Type: Theses and Dissertations
Appears in Collections:PhD theses
Research publications

Files in This Item:
File Description SizeFormat 
Annegret Van Der Aa.pdf13.6 MBAdobe PDFView/Open
Show full item record

Page view(s)

checked on May 25, 2022


checked on May 25, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.